Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus–induced type 2 responses and immunopathology

Publication date: August 2018

Source: Journal of Allergy and Clinical Immunology, Volume 142, Issue 2

Author(s): Melissa H. Bloodworth, Mark Rusznak, Connor C. Pfister, Jian Zhang, Lisa Bastarache, Sandra Alvarez Calvillo, James D. Chappell, Kelli L. Boyd, Shinji Toki, Dawn C. Newcomb, Matthew T. Stier, Weisong Zhou, Kasia Goleniewska, Martin L. Moore, Tina V. Hartert, Kevin D. Niswender, R. Stokes Peebles

https://ift.tt/2OIzg5w